newsfilter
← Latest News
PR Newswire·

Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results

ZBH
  • Zimmer Biomet reported fourth quarter 2025 net sales of $2.244 billion, a 10.9% increase on a reported basis.
  • Full-year 2025 net sales reached $8.232 billion, representing a 7.2% increase from the prior year.
  • Fourth quarter diluted EPS was $0.70, down 41.7%, while adjusted diluted EPS was $2.42, up 4.8%.
  • Full-year diluted EPS was $3.55, down 19.9%, while adjusted diluted EPS was $8.20, up 2.5%.
  • The company generated $1.697 billion in operating cash flow and $1.172 billion in free cash flow for the full year 2025.
  • Zimmer Biomet's Board approved a new $1.5 billion stock repurchase authorization commencing February 9, 2026, with no expiration date.
  • Full-year 2026 financial guidance includes reported revenue growth of 2.5% to 4.5% and adjusted diluted EPS of $8.30 to $8.45.
  • U.S. sales growth for the fourth quarter was 11.1% on a reported basis, with international sales growing 10.6%.
  • Product category growth in Q4 2025 was led by S.E.T. (Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic) with a 20.1% reported increase.
  • Recent highlights include FDA clearance for ROSA Knee with OptimiZe, the first iodine-treated hip procedure in Japan, and the launch of the Brachiator Mini-Rail External Fixation System.
  • The company named its CEO Ivan Tornos as highlighting strategic progress despite tariff headwinds and a planned transition to a direct U.S. sales organization.
  • The company received $250 million in share repurchases during the fourth quarter of fiscal 2025 prior to the new authorization.
  • Zimmer Biomet was named to Forbes' 2026 list of America's Best Companies.
  • Geographic sales data showed U.S. net sales of $4.764 billion for the full year 2025, while international sales totaled $3.467 billion.
  • The acquisition of Paragon 28 in April 2025 is excluded from organic constant currency growth calculations.
  • The company reported total assets of $23.092 billion as of December 31, 2025.
  • Long-term debt increased to $6.932 billion from $5.342 billion in the prior year period.